Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Alliacense

Although TPL announced that Alliacense would handle the licensing, Alliacense is not a part of the Master Agreement. Hence TPL could have turned over the job to another entity without needing any advice or consent from PTSC. But PDS would be aware of any change, and hence PTSC would be aware of any change.

Is PTSC obliged to tell us? Probably not, and there might be good reasons for not doing so. But we should be asking.

GLTA in 2010, Opty

Share
New Message
Please login to post a reply